维普期刊资源整合服务平台（V6.5）

113篇 您的检索式：作者名="Tempero"

选中清除导出查看参考文献查看引证文献引用追踪共6页首页上一页第1页下一页末页 /6 跳转

	题名	作者	年代	出处	被引量
1	Therapeutic Advances in Pancreatic Cancer显示文摘	Andrew Scott Paulson Hop S. Tran Cao Margaret A. Tempero Andrew M. Lowy	2013	Gastroenterology2013，，6：	4
2	Intracellular accumulation of unconjugated bilirubin inhibits phytohemagglutin -induced proliferation and interleukin - 2 production of human lymphocytes显示文摘	Haga Y Tempero MA Kay D	1996	Dig Dis Sci1996，41，7：	1
3	Lymphatic malformations:review of current treatment显示文摘	Perkins JA Manning SC Tempero RM	2010	Otolaryngol Head Neck Surg2010，142，6：	1
4	Randomized phase II comparison of dose-intense gem-citabine:thirty-minute infusion and fixed dose rate in-fusion in patients with pancreatic adenocarcinoma显示文摘	Tempero M Plunkett W Ruiz Van Haperen V	2003	JClin Oncol2003，21，34：	1
5	Bile acids, ornithine decarboxylase, and cell proliferation in colon cancer: a review显示文摘	TEMPERO M	1986	Dig Dis1986，4，1：	1
6	Unconjugated bilirubin inhibits in vitro cytotoxic T lymphocyte activity of human lymphocytes 显示文摘	Haga Y Tempero MA Zetterman RK	1996	Biochim Biophys Acta1996，1317，1：	1
7	Randomized pahse 2 comparison of dose-intense gemcitabine: thirty-minute infusion and fixed dose rate infusion in patients with pancreatic adenocarcinoma显示文摘	Tempero M Plunkett W Ruiz Van Haperen V	2003	J clin oncol2003，21，18：	1
8	Pancreatic cancer treatment and research:an international expert panel discussion显示文摘	Tempero MA Berlin J Ducreux M	2011	Ann Oncol2011，22，7：	1
9	Relationship of carbohydrate antigen 19-9 and Lewis antigens in pancreatic cancer显示文摘	Tempero MA Uchida E Takasaki H		0，，20：	1
10	Pancreatic cancer treatment and research: an international expert panel discussion显示文摘	Tempero MA Berlin J Ducreux M	2011	Ann Oncol2011，22，7：	1
11	Pharmacokinetics and dose proportionality of fentanyl effervescent buccal tablets in healthy volunteers显示文摘	DARWlSH M TEMPERO K KIRBY M	2005	Clin Pharmacokinet2005，44，12：	1
12	Lymphatic mal-formations :current cellular and clinical investigations 显示文摘	Perkins JA Manning SC Tempero RM	2010	Otolaryngol Head Neck Surg2010，42，6：	1
13	The chemistry,pharmacology and clinical pharmacology of diflunisal显示文摘	Cirillo VJ Tempero KF	1978	Curr Med Res Opin1978，5，：	1
14	Randomized phase Ⅱ comparison of dose-intense gemcitabine: thirty-minute infusion and fixed dose rate infusion in patients with pancreatic adenocar- cinoma显示文摘	Tempero M Plunkett W Ruiz VHV	2003	J Clin Oneol2003，21，18：	1
15	A phase II study of bevacizumab plus erlotinib for gemcitabine-refractory metastatic pancreatic cancer显示文摘	Andrew H. Ko Alan P. Venook Emily K. Bergsland R. Kate Kelley W. Michael Korn Elizabeth Dito Brian Schillinger Janet Scott Jimmy Hwang Margaret A. Tempero	2010	Cancer Chemotherapy and Pharmacology2010，，6：	1
16	Randomized phase Ⅱ study of gemcitabine administered at a fixed dose rate or in combination with cisplatin, doeetaxel, or irinotecan in patients with metastatic pancreatic cancer: CALGB 89904显示文摘	Kulke MH Tempero MA Niedzwiecki D	2009	J Clin Oncol2009，27，33：	1
17	Lymphatic malformations : Current cellular and clinical investigations显示文摘	PerkinsJA Manning SC Tempero RM	2010	Otolaryngol Head Neck Surg2010，142，：	1
18	Organ-specific pancreatic tumor growth properties and tumor immunity显示文摘	Morikane K Muto T Tempero R	1997	Cancer Immunol Immunother1997，47，：	1
19	Unconjugated bilirubin inhibits in vitro major histocompatibility complex-unrestricted cytotoxicity of human lymphocytes显示文摘	Haga Y Tempero MA Zetterman RK	1996	Biochim Biophys Acta1996，1316，1：	1
20	A Phase I Study of FOLFIRINOX Plus IPI-926, a Hedgehog Pathway Inhibitor, for Advanced Pancreatic Adenocarcinoma显示文摘	Andrew H. Ko Noelle LoConte Margaret A. Tempero Evan J. Walker R. Kate Kelley Stephanie Lewis Wei-Chou Chang Emily Kantoff Michael W. Vannier Daniel V. Catenacci Alan P. Venook Hedy L. Kindler	2016	Pancreas2016，，3：	1

返回顶部每页显示：

共6页首页上一页第1页下一页末页 /6 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示